Assay Detail
Binding
CHEMBL5731884
Review assay metadata, readout intent, target linkage, and publication context from the same page.
DPP-IV Inhibitory Activity: 1. DPP-IV enzyme reaction buffer was prepared (50 mM HEPES (pH=7.8), 80 mM MgCl2, 150 mM NaCl, 1% BSA), and stored on ice for use; 2. The test compounds were diluted with DMSO from 10 mM to 1 mM (100-fold final concentration), and then diluted gradiently 3 folds in a 96-well plate to obtain 11 concentrations; DMSO was added to the twelfth well as a blank control, and then diluted 25 folds with the enzyme reaction buffer to 4-fold final concentration for use; 3. The DPP-IV enzyme reaction substrate H-Gly-Pro-AMC was thawed and diluted to 160 uM (4-fold final concentration) with the enzyme reaction buffer, and then stored on ice for use; 4. The rat plasma was thawed and diluted 100 folds (2-fold final concentration) with the enzyme reaction buffer, and then stored on ice for use; 5. 5 uL of the test compounds (4-fold final concentration) were added to a 384-well plate, and then L of the rat plasma (2-fold final concentration) was added, centrifuged and mixed well; 6. 5 uL of the enzyme reaction substrate H-Gly-Pro-AMC (4-fold final concentration) was added, centrifuged and mixed well, and then the 384-well plate was sealed with a film; 7. The resulting mixture was incubated in an incubator (22-23 C.) for 1 hour; 8. The fluorescence signal was determined using FlexStationI3 (Molecular devices) microplate reader (excited at 380 nm, and the emission spectrum was determined at 460 nm wavelength); 9. IC50 values of the test compounds in inhibiting DPP-IV activity were determined, i.e., calculating the IC50 values of the compounds using GraFit6 software.
24
Total Activities
8
Compounds Tested
3
Activity Types
0
Assay Parameters
Assay Information
| Assay Type | Binding |
| Organism | Homo sapiens |
| Confidence | 9 — Direct single protein target |
| Curated By | Autocuration |
Publication
Substituted amino six-membered saturated heteroalicycles as long-acting DPP-IV inhibitors
Activity Statistics
| Type | Count | Avg pChEMBL | Best pChEMBL |
|---|---|---|---|
| IC50 | 8 | 8.31 | 8.59 |
| kon | 8 | - | - |
| k_off | 8 | - | - |
Compounds Tested
| Compound | Name | Phase | Activities | Best pChEMBL |
|---|---|---|---|---|
| CHEMBL5828032 | — | — | 3 | 8.59 |
| CHEMBL5894572 | — | — | 3 | 8.49 |
| CHEMBL5763347 | — | — | 3 | 8.42 |
| CHEMBL2105762 | OMARIGLIPTIN | 4.0 | 3 | 8.38 |
| CHEMBL5891902 | — | — | 3 | 8.36 |
| CHEMBL5790948 | — | — | 3 | 8.29 |
| CHEMBL5791601 | — | — | 3 | 8.19 |
| CHEMBL6043018 | — | — | 3 | 7.74 |
Activity Data
| Compound | Name | Type | Rel. | Value | Units | pChEMBL |
|---|---|---|---|---|---|---|
| CHEMBL5828032 | — | IC50 | = | 2.6 | nM | 8.59 |
| CHEMBL5894572 | — | IC50 | = | 3.2 | nM | 8.49 |
| CHEMBL5763347 | — | IC50 | = | 3.8 | nM | 8.42 |
| CHEMBL2105762 | OMARIGLIPTIN | IC50 | = | 4.2 | nM | 8.38 |
| CHEMBL5891902 | — | IC50 | = | 4.4 | nM | 8.36 |
| CHEMBL5790948 | — | IC50 | = | 5.1 | nM | 8.29 |
| CHEMBL5791601 | — | IC50 | = | 6.5 | nM | 8.19 |
| CHEMBL6043018 | — | IC50 | = | 18.2 | nM | 7.74 |
| CHEMBL2105762 | OMARIGLIPTIN | kon | = | - | — | - |
| CHEMBL2105762 | OMARIGLIPTIN | k_off | = | - | s-1 | - |
| CHEMBL5891902 | — | kon | = | - | — | - |
| CHEMBL5891902 | — | k_off | = | - | s-1 | - |
| CHEMBL5790948 | — | kon | = | - | — | - |
| CHEMBL5790948 | — | k_off | = | - | s-1 | - |
| CHEMBL6043018 | — | kon | = | - | — | - |
| CHEMBL6043018 | — | k_off | = | - | s-1 | - |
| CHEMBL5828032 | — | kon | = | - | — | - |
| CHEMBL5828032 | — | k_off | = | - | s-1 | - |
| CHEMBL5791601 | — | kon | = | - | — | - |
| CHEMBL5791601 | — | k_off | = | - | s-1 | - |
| CHEMBL5763347 | — | kon | = | - | — | - |
| CHEMBL5763347 | — | k_off | = | - | s-1 | - |
| CHEMBL5894572 | — | kon | = | - | — | - |
| CHEMBL5894572 | — | k_off | = | - | s-1 | - |